Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia
| dc.creator | Flavia Lucena | |
| dc.creator | Luci Dusse | |
| dc.creator | Eura Martins Lage | |
| dc.creator | Patricia Gonçalves Teixeira | |
| dc.creator | Alexandre Simões Barbosa | |
| dc.creator | Rejane Diniz | |
| dc.creator | Andre Talvani Pedrosa da Silva | |
| dc.creator | Patricia Alpoim | |
| dc.creator | Luisa Perucci | |
| dc.creator | Bashir Lwaleed | |
| dc.date.accessioned | 2023-07-14T19:57:25Z | |
| dc.date.accessioned | 2025-09-09T00:22:28Z | |
| dc.date.available | 2023-07-14T19:57:25Z | |
| dc.date.issued | 2019-02-13 | |
| dc.identifier.doi | https://doi.org/10.1080/10641955.2019.1577435 | |
| dc.identifier.issn | 10641955 | |
| dc.identifier.uri | https://hdl.handle.net/1843/56268 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Hypertension in Pregnancy | |
| dc.rights | Acesso Restrito | |
| dc.subject | Pré-Eclâmpsia | |
| dc.subject | Estudos Longitudinais | |
| dc.subject | Trombofilia | |
| dc.subject.other | Preemclampisia | |
| dc.subject.other | D-dimer | |
| dc.subject.other | Longitudinal Study | |
| dc.subject.other | Pai 1 | |
| dc.subject.other | Hypercoagulability | |
| dc.title | Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 6 | |
| local.citation.issue | 1 | |
| local.citation.spage | 1 | |
| local.citation.volume | 38 | |
| local.description.resumo | Objective: Investigating D-Dimer/D-Di and plasminogen activator inhibitor type-1/PAI-1 levels throughout gestation in women with preeclampsia/PE risk factors.Methods: D-Di and PAI-1 plasma levels were determined in 28 women at 12–19, 20–29, 30–34 and 35–40 weeks of gestation.Results: D-Di was lower at 12–19 weeks and higher at 30–34 weeks in women who developed PE versus who did not develop it. D-Di increased throughout gestation in both groups, peaking earlier in pregnant women who developed PE versus who did not develop it. PA1-1 increased across gestation, but it didn’t differ between groups. Conclusion: D-Di was able to discriminate these groups of women at 12–19 and 30–34 weeks of gestation. | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | MED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.tandfonline.com/doi/abs/10.1080/10641955.2019.1577435?journalCode=ihip20 |
Arquivos
Licença do pacote
1 - 1 de 1